
Five Distinct Subtypes of Common Liver Disease Identified in Mayo Clinic Study
Mayo Clinic researchers identified five subtypes of common liver disease, highlighting different risks and more precise treatment possibilities.
The latest on inflammatory bowel disease, liver disease, gut health and other conditions of the digestive system.

Mayo Clinic researchers identified five subtypes of common liver disease, highlighting different risks and more precise treatment possibilities.

Researchers identify early molecular warning signs of inflammatory bowel disease, offering clues for earlier diagnosis and treatment.

Researchers identify early molecular warning signs of inflammatory bowel disease, raising hopes for earlier diagnosis and care.

Researchers found silent molecular signs of IBD that may predict flare-ups earlier and improve treatment monitoring.

New research reveals hidden gut-cell warning signs in IBD, opening the door to earlier flare prediction and more tailored treatment.

New research on inflammatory bowel disease highlights early molecular warning signs that could support earlier diagnosis.

Researchers identify hidden early warning signs of inflammatory bowel disease that could improve monitoring and flare-up prediction.

Fluconazole may improve inflammatory bowel disease outcomes by altering gut microbiome dynamics, a new study suggests.
A large genetic study suggests a marker could help identify IBD patients at risk of severe Crohn’s disease and ulcerative colitis earlier.
NICE proposes routine NHS use of liver preservation machines to improve transplant access and reduce waiting-list inequity.